Patterns of Recurrence and outcome according to breast cancer subtypes in lymph node-negative disease: results from international breast cancer study group trials VIII and IX.
about
Follow-up strategies for women treated for early breast cancerThe hedgehog pathway in triple-negative breast cancerEmerging role of cell polarity proteins in breast cancer progression and metastasisQuantitative MRI radiomics in the prediction of molecular classifications of breast cancer subtypes in the TCGA/TCIA data setYoung Age Is Associated with Increased Locoregional Recurrence in Node-Positive Breast Cancer with Luminal Subtypes.ID2 predicts poor prognosis in breast cancer, especially in triple-negative breast cancer, and inhibits E-cadherin expressionOmitting re-excision for focally positive margins after breast-conserving surgery does not impair disease-free and overall survivalEstablishment of a risk scoring system for predicting locoregional recurrence in T1 to T2 node-negative breast cancer patients treated with mastectomy: Implications for postoperative radiotherapy.Predictors of recurrence in breast cancer subtypes with negative lymph node in a Chinese population.Systematic analysis of metastasis-associated genes identifies miR-17-5p as a metastatic suppressor of basal-like breast cancer.The PI3K/mTOR dual inhibitor P7170 demonstrates potent activity against endocrine-sensitive and endocrine-resistant ER+ breast cancer.Breast cancer "tailored follow-up" in Italian oncology units: a web-based survey.Estrogen receptor, progesterone receptor, and HER2 status predict lymphovascular invasion and lymph node involvementEarly detection of metastatic disease in asymptomatic breast cancer patients with whole-body imaging and defined tumour marker increase.Solid Predominant Histologic Subtype in Resected Stage I Lung Adenocarcinoma Is an Independent Predictor of Early, Extrathoracic, Multisite Recurrence and of Poor Postrecurrence SurvivalTumor Invasiveness, Not Lymphangiogenesis, Is Correlated with Lymph Node Metastasis and Unfavorable Prognosis in Young Breast Cancer Patients (≤35 Years).Decreased hormonal sensitivity after childbirth rather than the tumor size influences the prognosis of very young breast cancer patients.Assessment of Tumor Heterogeneity, as Evidenced by Gene Expression Profiles, Pathway Activation, and Gene Copy Number, in Patients with Multifocal Invasive Lobular Breast Tumors.Relative Effectiveness of Letrozole Compared With Tamoxifen for Patients With Lobular Carcinoma in the BIG 1-98 Trial.Evaluation of clinical parameters influencing the development of bone metastasis in breast cancer.Low-Dose Oral Cyclophosphamide and Methotrexate Maintenance for Hormone Receptor-Negative Early Breast Cancer: International Breast Cancer Study Group Trial 22-00.Difference between observed and expected number of involved lymph nodes reflects the metastatic potential of breast cancer independent to intrinsic subtypeRadiomic analysis reveals DCE-MRI features for prediction of molecular subtypes of breast cancer.miR-34a Silences c-SRC to Attenuate Tumor Growth in Triple-Negative Breast Cancer.Comparison of Predictive Immunohistochemical Marker Expression of Primary Breast Cancer and Paired Distant Metastasis using Surgical Material: A Practice-Based StudyDisrupting VEGF-A paracrine and autocrine loops by targeting SHP-1 suppresses triple negative breast cancer metastasis.Annual Hazard Rates of Recurrence for Breast Cancer During 24 Years of Follow-Up: Results From the International Breast Cancer Study Group Trials I to V.Luteolin inhibits lung metastasis, cell migration, and viability of triple-negative breast cancer cells.Patterns of distant metastasis in Chinese women according to breast cancer subtypesConditional disease-free survival among patients with breast cancer.Bone metastasis risk factors in breast cancer.Luminal B breast cancer: patterns of recurrence and clinical outcome.HER2-positive endometrial cancer subtype carries poor prognosis.Magnetic resonance imaging in patients with newly diagnosed breast cancer: a review of the literature.Is mastectomy undertreatment for low-risk breast cancers eligible for breast-conserving therapy?Comparative diagnostic accuracy of 18F-FDG PET/CT for breast cancer recurrence.Survival with metastatic breast cancer based on initial presentation, de novo versus relapsed.Role of dietary bioactive natural products in estrogen receptor-positive breast cancer.Regional Nodal Irradiation After Breast Conserving Surgery for Early HER2-Positive Breast Cancer: Results of a Subanalysis From the ALTTO Trial.News on the medical treatment of young women with early-stage HER2-negative breast cancer.
P2860
Q26471890-09FFBFAC-E4A1-41CD-8FAA-7C76AA76075FQ26740373-A3037173-8C77-4930-8E02-48F6E4BE032DQ26851833-D19DB236-F45D-4B9A-8C56-89B6381C0ED7Q31142731-C4D51F61-6407-48DB-B23D-88EAD54BDCE7Q33584079-3B6F7E44-9803-4A6A-A219-9D5C4E660083Q33800620-904F5E1E-6397-4579-B130-97B4D0A76CECQ33843726-E39D066E-EFDF-4488-A8B7-454815B2E8B3Q33879820-8CAE7A44-3362-4986-8935-6761E636634FQ33898517-5D5526C6-FE09-4745-8FF8-174CF7D4B09FQ34049023-5275A9C1-0AEB-4309-A964-47D6ACFC6434Q34995919-B148CA30-2653-48EB-BDB0-99BF5D65136FQ35143022-19C73978-57DD-44A3-926E-257CF55E4880Q35184621-CBE3F8C4-603B-4687-9B26-E4CD452A50C6Q35678734-22FC4830-148D-4AAC-BF7C-F67715C7B770Q35742165-8178939C-F786-47E1-B9F1-2C80E7604B34Q35866159-F0920F97-8C76-4617-BBCA-C362E86A9455Q35868296-6E968649-29FC-4EE2-A91F-F778B5FD14CBQ35990106-0481A163-BBC7-414B-9B65-86923687C385Q35998828-BEAABF14-74E8-4369-9B99-36DF6FCDEF9EQ36016851-EBFAA665-307E-42CD-8FDF-1FFC98248642Q36057458-1CE3756C-A18A-4036-82BB-F2315BE4C22AQ36140917-5DE0E726-68D4-4C2F-A6FF-6A8871685402Q36271681-48A15F27-7686-4B22-9838-947807C7EACCQ36586444-94D967BF-E616-434D-8265-E1443C910C79Q36756659-5670CD70-E03B-4ACC-BB30-C46D7C0DEF46Q37057268-A69AEB7C-D593-47A8-B147-F4B211FA62C1Q37065597-9A15A314-DBFB-4444-979E-B7D27AD9998AQ37551677-6001F885-D51E-4713-A7E3-DA362A5D3AB8Q37565346-37590B3D-33D9-439F-AE38-0C38D06C3ECBQ37582617-A4D369B3-4AE6-4932-94BE-20AB641691DDQ37629662-03CDE4DA-1E77-4E78-919F-8E53306C8F5DQ37662184-755AAE3D-46BD-4EE6-B0BA-44BB503B391EQ37700593-B89C4FC1-7E17-4395-BFAE-9328B833D00CQ38206146-54FD3B5D-1D50-4E3A-A36B-36515FDC2A6FQ38446546-81456A26-710A-4524-A6BE-D039F3AEE4B1Q38663416-2CFB6DAF-73D4-4E09-A09B-D83481ADB72BQ38779946-E092678A-5AD8-47E0-BF36-4A21ADFCB3FAQ38789308-6AA339E3-65D4-4CF3-8CF8-E7C5D7C2E617Q38855652-3726C1B8-FE21-4765-9EBE-C706B1D1D7DCQ38870541-592CBABF-0439-4A56-8DE8-04EB703571A9
P2860
Patterns of Recurrence and outcome according to breast cancer subtypes in lymph node-negative disease: results from international breast cancer study group trials VIII and IX.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 29 July 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Patterns of Recurrence and out ...... tudy group trials VIII and IX.
@en
Patterns of Recurrence and out ...... tudy group trials VIII and IX.
@nl
type
label
Patterns of Recurrence and out ...... tudy group trials VIII and IX.
@en
Patterns of Recurrence and out ...... tudy group trials VIII and IX.
@nl
prefLabel
Patterns of Recurrence and out ...... tudy group trials VIII and IX.
@en
Patterns of Recurrence and out ...... tudy group trials VIII and IX.
@nl
P2093
P2860
P356
P1476
Patterns of Recurrence and out ...... tudy group trials VIII and IX.
@en
P2093
Alan S Coates
Aron Goldhirsch
Diana Crivellari
Fatima Cardoso
Karen N Price
Monica Castiglione-Gertsch
Otto Metzger-Filho
Raymond D Snyder
Richard D Gelber
Zhuoxin Sun
P2860
P304
P356
10.1200/JCO.2012.46.1574
P407
P577
2013-07-29T00:00:00Z